WELL HEALTH TECHNOLOGIES COR (WELL.CA) Stock Fundamental Analysis
TSX:WELL - Toronto Stock Exchange - CA94947L1022 - Common Stock - Currency: CAD
Taking everything into account, WELL scores 3 out of 10 in our fundamental rating. WELL was compared to 15 industry peers in the Health Care Providers & Services industry. WELL has a bad profitability rating. Also its financial health evaluation is rather negative. WELL has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year WELL has reported negative net income.
In the past year WELL had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: WELL reported negative net income in multiple years.
WELL had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
With a decent Return On Assets value of -1.60%, WELL is doing good in the industry, outperforming 62.50% of the companies in the same industry.
WELL has a Return On Equity (-3.48%) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.6% | ||
| ROE | -3.48% | ||
| ROIC | N/A |
ROA(3y)0.64%
ROA(5y)-0.59%
ROE(3y)1.32%
ROE(5y)-0.98%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
WELL has a Gross Margin of 38.51%. This is in the better half of the industry: WELL outperforms 62.50% of its industry peers.
In the last couple of years the Gross Margin of WELL has grown nicely.
WELL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 38.51% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.09%
GM growth 5Y3.31%
2. Health
2.1 Basic Checks
WELL does not have a ROIC to compare to the WACC, probably because it is not profitable.
WELL has more shares outstanding than it did 1 year ago.
The number of shares outstanding for WELL has been increased compared to 5 years ago.
WELL has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.03, we must say that WELL is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of WELL (1.03) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.59 indicates that WELL is somewhat dependend on debt financing.
WELL has a better Debt to Equity ratio (0.59) than 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.59 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.03 |
ROIC/WACCN/A
WACC7.27%
2.3 Liquidity
WELL has a Current Ratio of 0.92. This is a bad value and indicates that WELL is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.92, WELL is in the better half of the industry, outperforming 68.75% of the companies in the same industry.
WELL has a Quick Ratio of 0.92. This is a bad value and indicates that WELL is not financially healthy enough and could expect problems in meeting its short term obligations.
WELL has a Quick ratio of 0.92. This is in the better half of the industry: WELL outperforms 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.92 | ||
| Quick Ratio | 0.92 |
3. Growth
3.1 Past
WELL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -200.00%.
Looking at the last year, WELL shows a quite strong growth in Revenue. The Revenue has grown by 17.19% in the last year.
The Revenue has been growing by 94.78% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-337.5%
Revenue 1Y (TTM)17.19%
Revenue growth 3Y44.9%
Revenue growth 5Y94.78%
Sales Q2Q%27.02%
3.2 Future
Based on estimates for the next years, WELL will show a very strong growth in Earnings Per Share. The EPS will grow by 30.85% on average per year.
Based on estimates for the next years, WELL will show a quite strong growth in Revenue. The Revenue will grow by 13.73% on average per year.
EPS Next Y46.2%
EPS Next 2Y30.38%
EPS Next 3Y30.92%
EPS Next 5Y30.85%
Revenue Next Year40.99%
Revenue Next 2Y22.96%
Revenue Next 3Y17.8%
Revenue Next 5Y13.73%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for WELL. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 15.84, the valuation of WELL can be described as correct.
Compared to the rest of the industry, the Price/Forward Earnings ratio of WELL indicates a rather cheap valuation: WELL is cheaper than 93.75% of the companies listed in the same industry.
WELL is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.77, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 15.84 |
4.2 Price Multiples
WELL's Enterprise Value to EBITDA ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 33.23 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
WELL's earnings are expected to grow with 30.92% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.38%
EPS Next 3Y30.92%
5. Dividend
5.1 Amount
WELL does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:WELL (5/23/2025, 7:00:00 PM)
4.04
-0.05 (-1.22%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners6.33%
Inst Owner ChangeN/A
Ins Owners8.41%
Ins Owner ChangeN/A
Market Cap1.02B
Analysts81
Price Target7.8 (93.07%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-661.05%
Min EPS beat(2)-1116.23%
Max EPS beat(2)-205.87%
EPS beat(4)1
Avg EPS beat(4)4130.26%
Min EPS beat(4)-3335.29%
Max EPS beat(4)21178.4%
EPS beat(8)2
Avg EPS beat(8)1642.24%
EPS beat(12)3
Avg EPS beat(12)973.71%
EPS beat(16)3
Avg EPS beat(16)622.27%
Revenue beat(2)1
Avg Revenue beat(2)-5.51%
Min Revenue beat(2)-12.61%
Max Revenue beat(2)1.59%
Revenue beat(4)2
Avg Revenue beat(4)-2.66%
Min Revenue beat(4)-12.61%
Max Revenue beat(4)1.59%
Revenue beat(8)4
Avg Revenue beat(8)-0.92%
Revenue beat(12)7
Avg Revenue beat(12)0.22%
Revenue beat(16)11
Avg Revenue beat(16)1.27%
PT rev (1m)-10%
PT rev (3m)-11.85%
EPS NQ rev (1m)100%
EPS NQ rev (3m)100%
EPS NY rev (1m)0%
EPS NY rev (3m)36.27%
Revenue NQ rev (1m)24.9%
Revenue NQ rev (3m)24.9%
Revenue NY rev (1m)0.42%
Revenue NY rev (3m)21.29%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 15.84 | ||
| P/S | 1.04 | ||
| P/FCF | N/A | ||
| P/OCF | 81.86 | ||
| P/B | 1.23 | ||
| P/tB | N/A | ||
| EV/EBITDA | 33.23 |
EPS(TTM)-0.12
EYN/A
EPS(NY)0.26
Fwd EY6.31%
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)0.05
OCFY1.22%
SpS3.88
BVpS3.3
TBVpS-1.36
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.6% | ||
| ROE | -3.48% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 38.51% | ||
| FCFM | N/A |
ROA(3y)0.64%
ROA(5y)-0.59%
ROE(3y)1.32%
ROE(5y)-0.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.09%
GM growth 5Y3.31%
F-Score3
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.59 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 11.42 | ||
| Cap/Depr | 26.64% | ||
| Cap/Sales | 2.04% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 28.75% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.92 | ||
| Quick Ratio | 0.92 | ||
| Altman-Z | 1.03 |
F-Score3
WACC7.27%
ROIC/WACCN/A
Cap/Depr(3y)15.79%
Cap/Depr(5y)16.17%
Cap/Sales(3y)1.31%
Cap/Sales(5y)1.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-337.5%
EPS Next Y46.2%
EPS Next 2Y30.38%
EPS Next 3Y30.92%
EPS Next 5Y30.85%
Revenue 1Y (TTM)17.19%
Revenue growth 3Y44.9%
Revenue growth 5Y94.78%
Sales Q2Q%27.02%
Revenue Next Year40.99%
Revenue Next 2Y22.96%
Revenue Next 3Y17.8%
Revenue Next 5Y13.73%
EBIT growth 1Y-191.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year269.34%
EBIT Next 3Y60.62%
EBIT Next 5Y44.11%
FCF growth 1Y-110.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-84.54%
OCF growth 3Y-22.85%
OCF growth 5YN/A